Conning Inc. Pfizer Inc Transaction History

Conning Inc.

$2.67 Billion
Q2 2024

A detailed history of Conning Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Conning Inc. holds 78,909 shares of PFE stock, worth $2.28 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

78,909

Previous 144,637 45.44%

Holding current value

$2.28 Million

Previous $4.01 Million 45.0%

% of portfolio

0.08%

Previous 0.14%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$25.26 - $29.6 $1.66 Million - $1.95 Million	-65,728 Reduced 45.44%	78,909 $2.21 Million
Q1 2024 Apr 26, 2024	SELL	$25.89 - $29.73 $27.5 Million - $31.6 Million	-1,063,488 Reduced 88.03%	144,637 $4.01 Million
Q4 2023 Jan 29, 2024	BUY	$26.13 - $33.94 $3.73 Million - $4.85 Million	142,872 Added 13.41%	1,208,125 $34.8 Million
Q3 2023 Oct 26, 2023	BUY	$32.09 - $37.51 $2.69 Million - $3.15 Million	83,876 Added 8.55%	1,065,253 $35.3 Million
Q2 2023 Jul 21, 2023	BUY	$36.12 - $41.79 $807,534 - $934,299	22,357 Added 2.33%	981,377 $36 Million
Q1 2023 Apr 27, 2023	BUY	$39.39 - $51.28 $6.22 Million - $8.1 Million	157,925 Added 19.71%	959,020 $39.1 Million
Q4 2022 Feb 07, 2023	SELL	$41.75 - $54.5 $1.55 Million - $2.02 Million	-37,029 Reduced 4.42%	801,095 $41.1 Million
Q3 2022 Oct 28, 2022	SELL	$43.76 - $53.42 $3.73 Million - $4.56 Million	-85,272 Reduced 9.23%	838,124 $36.6 Million
Q2 2022 Jul 20, 2022	SELL	$46.53 - $55.17 $4.71 Million - $5.59 Million	-101,235 Reduced 9.88%	923,396 $48.4 Million
Q1 2022 May 02, 2022	BUY	$45.75 - $56.69 $1.53 Million - $1.89 Million	33,383 Added 3.37%	1,024,631 $53 Million
Q4 2021 Jan 27, 2022	SELL	$41.32 - $61.25 $8.02 Million - $11.9 Million	-194,026 Reduced 16.37%	991,248 $58.5 Million
Q3 2021 Nov 05, 2021	SELL	$39.25 - $50.42 $9.08 Million - $11.7 Million	-231,306 Reduced 16.33%	1,185,274 $50.9 Million
Q2 2021 Jul 29, 2021	SELL	$35.91 - $40.68 $3.94 Million - $4.46 Million	-109,690 Reduced 7.19%	1,416,580 $55.4 Million
Q1 2021 Apr 23, 2021	BUY	$33.49 - $37.77 $7.25 Million - $8.18 Million	216,599 Added 16.54%	1,526,270 $55.3 Million
Q4 2020 Jan 28, 2021	BUY	$33.47 - $42.56 $1.49 Million - $1.9 Million	44,610 Added 3.53%	1,309,671 $48.2 Million
Q3 2020 Oct 21, 2020	BUY	$31.75 - $37.25 $1.95 Million - $2.29 Million	61,543 Added 5.11%	1,265,061 $46.4 Million
Q2 2020 Aug 07, 2020	SELL	$30.12 - $36.54 $4.35 Million - $5.27 Million	-144,350 Reduced 10.71%	1,203,518 $39.4 Million
Q1 2020 Apr 29, 2020	BUY	$27.03 - $38.62 $1.3 Million - $1.85 Million	47,937 Added 3.69%	1,347,868 $44 Million
Q4 2019 Jan 29, 2020	BUY	$32.92 - $37.36 $1.35 Million - $1.53 Million	40,872 Added 3.25%	1,299,931 $50.9 Million
Q3 2019 Oct 30, 2019	BUY	$32.49 - $42.13 $5.08 Million - $6.59 Million	156,384 Added 14.18%	1,259,059 $45.2 Million
Q2 2019 Jul 25, 2019	SELL	$36.98 - $41.52 $1.82 Million - $2.05 Million	-49,264 Reduced 4.28%	1,102,675 $47.8 Million
Q1 2019 Apr 22, 2019	BUY	$37.5 - $41.2 $1.1 Million - $1.21 Million	29,257 Added 2.61%	1,151,939 $48.9 Million
Q4 2018 Jan 29, 2019	SELL	$38.47 - $43.86 $5.51 Million - $6.28 Million	-143,183 Reduced 11.31%	1,122,682 $49 Million
Q3 2018 Oct 26, 2018	SELL	$34.47 - $41.81 $3.15 Million - $3.83 Million	-91,492 Reduced 6.74%	1,265,865 $55.8 Million
Q2 2018 Jul 25, 2018	BUY	$32.98 - $35.16 $1.67 Million - $1.78 Million	50,498 Added 3.86%	1,357,357 $49.2 Million
Q1 2018 May 04, 2018	BUY	$31.91 - $37.02 $3.67 Million - $4.25 Million	114,903 Added 9.64%	1,306,859 $46.4 Million
Q4 2017 Jan 30, 2018	SELL	$33.26 - $35.29 $387,146 - $410,775	-11,640 Reduced 0.97%	1,191,956 $43.2 Million
Q3 2017 Oct 20, 2017	BUY	$31.0 - $34.15 $37.3 Million - $41.1 Million	1,203,596	1,203,596 $43 Million

Others Institutions Holding PFE

# of Institutions

3,222

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $162B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Conning Inc., based on Form 13F filings with the SEC.

News

Stay updated on Conning Inc. with notifications on news.

Account